Galit Frydman Discusses JTH Research on Cerebral Vein Thrombosis Risk from Hormonal Contraceptives
Galit Frydman, Founder and Chief Scientific Officer of Coagulo Medical Technologies, Inc., reposted from Journal of Thrombosis and Haemostasis (JTH) on LinkedIn:
“Yet another example of how femtech needs more attention. Hormonal birth control is such a popular form of birth control, yet it can pose life-threatening adverse events to the woman using it.
I never realized how much women’s, maternal and fetal medicine was behind until I had my own pregnancy and child.
The market size is not a question here….why is funding and why are companies so far behind on these issues? (lots of reasons for this! but I thought it would start an interesting conversation on this platform)”
Journal of Thrombosis and Haemostasis (JTH) has shared a post on LinkedIn:
“The risk of cerebral vein thrombosis associated with different types of combined hormonal contraceptives: a case-control study
In this case-control study of 206 women with CVT and 868 controls, combined hormonal contraceptive (CHC) use was associated with a 10-fold higher risk of CVT. Risk increased with higher estrogen doses and was particularly elevated with fourth-generation pills (OR 28.3). Progestin-only and variable-dose CHCs carried a 6-fold increased risk. Importantly, thrombophilia and positive family history had synergistic effects, with odds ratios exceeding 200 in some subgroups.”
Title: The risk of cerebral vein thrombosis associated with different types of combined hormonal contraceptives: a case-control study
Authors: Maria Abbattista, Addolorata Truma, Ida Martinelli, Francesca Gianniello, Serena M. Passamonti, Marco Capecchi, Andrea Artoni, Flora Peyvandi, Paolo Bucciarelli
Read the full article here.
Stay updated with Hemostasis Today.
-
Sep 4, 2026, 16:38Felice Gragnano։ Turning Cardiovascular Risk Into Action
-
Sep 4, 2026, 16:30Lisa Littner: The Hidden Burden of Prior Authorization in Bleeding Disorder Care
-
Sep 4, 2026, 13:54Ahmad G. Alzahrani: A New Classification for Acute Pulmonary Embolism
-
Sep 4, 2026, 12:52James P. Crowley: MDS vs MPN – Understanding the Difference
-
Sep 4, 2026, 12:02Khalid Abdelsamea Mohamedahmed: Routine Blood Parameters in Pediatric Sickle Cell Anemia
-
Sep 4, 2026, 11:37Consuela A. Albright: The Power of Community Advocacy in Sickle Cell Disease
-
Sep 4, 2026, 11:18Aanika Roshni: When Blood, Biology, and Mechanics Intersect
-
Sep 4, 2026, 10:01Ifeanyichukwu Ifechidere: Making Coagulation Simpler and More Practical
-
Sep 4, 2026, 09:49Omid Khalafi: When the ‘Rules of Three’ Break – What Is Really Happening?